Ram Doolman

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Low factor XI activity in heart failure: A potential marker of disease severity?

Low factor XI activity in heart failure: A potential marker of disease severity?

Journal: Kardiologia polska

Published: March 09, 2026

Towards noninvasive blood count using a deep learning pipeline from bulbar conjunctiva videos.

Towards noninvasive blood count using a deep learning pipeline from bulbar conjunctiva videos.

Journal: NPJ digital medicine

Published: July 18, 2025

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.

Journal: Emerging infectious diseases

Published: April 26, 2024

Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines.

Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines.

Journal: Vaccine

Published: March 25, 2024

Corrigendum to "Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" [Clin Microbiol Infect] 29 (7) (2023) 918-923.

Corrigendum to "Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" [Clin Microbiol Infect] 29 (7) (2023) 918-923.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 21, 2023

Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines.

Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines.

Journal: JAMA network open

Published: September 08, 2023

Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel.

Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel.

Journal: JAMA network open

Published: May 23, 2023

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.

Journal: Nature communications

Published: March 23, 2023

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients.

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients.

Journal: Viruses

Published: December 16, 2022

Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up.

Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: November 26, 2022

Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant Recipients.

Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant Recipients.

Journal: Transplantation

Published: November 11, 2022

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.

Journal: The New England journal of medicine

Published: November 09, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026